United Republic of Tanzania vs Yemen: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
United Republic of Tanzania
0.4%
in 2024
Yemen
0.5%
in 2024
United Republic of Tanzania rank
74th
Yemen rank
71st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- United Republic of Tanzania
- Yemen
How they compare
Yemen currently reports 0.5% against 0.4% in United Republic of Tanzania, a difference of 0.1%.
That makes Yemen's figure about 1.2 times United Republic of Tanzania's.
Across all 10 years both countries report, Yemen has been ahead every year.
United Republic of Tanzania ranks 74th and Yemen ranks 71st of 246 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United Republic of Tanzania | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.6% | 0.0% | Yemen |
| 2020s | 0.4% | 0.5% | 0.1% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, United Republic of Tanzania or Yemen?
- Yemen, at 0.5% against 0.4% in United Republic of Tanzania as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between United Republic of Tanzania and Yemen?
- 0.1%, with Yemen ahead.
- How many years of comparable data are there for United Republic of Tanzania and Yemen?
- 10 years are reported by both, from 2015 to 2024.
- How do United Republic of Tanzania and Yemen rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- United Republic of Tanzania ranks 74th and Yemen ranks 71st of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.